Presentations 2014-2015

September 11th	Priya Londhe, PhD (Guttridge Lab) “Interferon gamma regulation of skeletal myogenesis” Shibi Likhite (Kaspar Lab) “AAV9-mediated gene therapy for therapeutic suppression of mutant SOD1 in Amyotrophic Lateral Sclerosis”	NCH WA1525
October 9th	Rui Xu PhD (Martin Lab) “Identifying roles for endogenous Galgt2 gene expression in muscular dystrophy” Sara Lampe, PhD (Foust Lab) “SMN insufficiency causes defective neuromuscular signaling to GI smooth muscle”	OSU DHLRI 165
November 13th	Trainee Poster Day	GRIGGS BOATHOUSE
December 11th	Russell Hepple, PhD McGill Research Centre for Physical Activity & Health “High-throughput genetic screens to define the mechanisms of neurodegenerative disease”	OSU DHLRI 165
January 8th	Aaron Gitler, MD, PhD Stanford University “High-throughput genetic screens to define the mechanisms of neurodegenerative disease”	NCH WA1525
February 12th	Stephen Kolb, MD, PhD. Ohio State University “Lessons learned from the NeuroNEXT Infant SMA Biomarker Study”	OSU DHLRI 165
March 12th	Louise Rodino-Klapac, PhD Nationwide Children’s Hospital “Gene replacement strategies for type 2 LGMDs”	NCH WA1525
April 9th	Matthew Husa, MD Ohio State University “The interaction of musculoskeletal tissues and immunity in age-associated osteoarthritis”	OSU DHLRI 165
May 14th	Charlotte Sumner, PhD John Hopkins University Title: TBA	NCH WA1525
June 11th	Heather Manring, PhD (Weisleder Lab) “Increasing membrane repair as a therapy for Duchenne Muscular Dystrophy” Joceyln Eidahl, PhD (Harper Lab) “Protein Chemistry of Myotoxic DUX4”	OSU DHLRI 165